Showing 5,901 - 5,920 results of 60,573 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.83s Refine Results
  1. 5901
  2. 5902
  3. 5903
  4. 5904
  5. 5905

    Table_1_Domesticating Vigna stipulacea: Chromosome-Level genome assembly reveals VsPSAT1 as a candidate gene decreasing hard-seededness.xlsx by Yu Takahashi (381135)

    Published 2023
    “…While doing so, we produced a V. stipulacea whole-genome assembly of 441 Mbp in 11 chromosomes and 30,963 annotated protein-coding sequences. …”
  6. 5906
  7. 5907

    Rat tickling: A systematic review of applications, outcomes, and moderators by Megan R. LaFollette (3911140)

    Published 2017
    “…The most common method used for tickling was cycling through 15 seconds of tickling and 15 seconds of rest for 2 minutes for 3 to 5 days. Experiments with a control for tickling (N = 22) showed that tickling increases positive vocalization, approach behavior, decreases anxiety measures, improves handling, and in some cases decreases stress hormones. …”
  8. 5908

    Effect of Prx-I-shRNA transfection on protein expression of phospho-NF-κB p50 and p65 in T24 cells by Western blots. by Li Jiang (120930)

    Published 2014
    “…<p>A significant decrease in the protein expression of both phospho-NF-κB p50 and p65 in sh-1 group. …”
  9. 5909
  10. 5910

    Anisotropic Evolution of Nanoclusters from Ag<sub>40</sub> to Ag<sub>45</sub>: Halogen- and Defect-Induced Epitaxial Growth in Nanoclusters by Wenjun Du (1883134)

    Published 2021
    “…Nanoclusters are the early morphology of nanoparticles and play an important role in revealing the formation and growth of nanoparticles due to their precise structures. Here, we report that halogens induce the anisotropic growth of Ag<sub>40</sub>(C<sub>6</sub>H<sub>5</sub>COO)<sub>13</sub>(SR)<sub>19</sub>(CH<sub>3</sub>CN) (<b>Ag</b><sub><b>40</b></sub><b>-II</b>, where SR = 4-<i>tert</i>-butylbenzylmercaptan) into Ag<sub>45</sub>(C<sub>6</sub>H<sub>5</sub>COO)<sub>13</sub>(SR)<sub>22</sub>Cl<sub>2</sub> (<b>Ag</b><sub><b>45</b></sub>), where <b>Ag</b><sub><b>40</b></sub><b>-II</b> is converted from Ag<sub>40</sub>(CH<sub>3</sub>COO)<sub>10</sub>(SR)<sub>22</sub> (<b>Ag</b><sub><b>40</b></sub><b>-I</b>). …”
  11. 5911

    Anisotropic Evolution of Nanoclusters from Ag<sub>40</sub> to Ag<sub>45</sub>: Halogen- and Defect-Induced Epitaxial Growth in Nanoclusters by Wenjun Du (1883134)

    Published 2021
    “…Nanoclusters are the early morphology of nanoparticles and play an important role in revealing the formation and growth of nanoparticles due to their precise structures. Here, we report that halogens induce the anisotropic growth of Ag<sub>40</sub>(C<sub>6</sub>H<sub>5</sub>COO)<sub>13</sub>(SR)<sub>19</sub>(CH<sub>3</sub>CN) (<b>Ag</b><sub><b>40</b></sub><b>-II</b>, where SR = 4-<i>tert</i>-butylbenzylmercaptan) into Ag<sub>45</sub>(C<sub>6</sub>H<sub>5</sub>COO)<sub>13</sub>(SR)<sub>22</sub>Cl<sub>2</sub> (<b>Ag</b><sub><b>45</b></sub>), where <b>Ag</b><sub><b>40</b></sub><b>-II</b> is converted from Ag<sub>40</sub>(CH<sub>3</sub>COO)<sub>10</sub>(SR)<sub>22</sub> (<b>Ag</b><sub><b>40</b></sub><b>-I</b>). …”
  12. 5912

    Table_5_miR-181a-5p Regulates TNF-α and miR-21a-5p Influences Gualynate-Binding Protein 5 and IL-10 Expression in Macrophages Affecting Host Control of Brucella abortus Infection.P... by Patrícia P. Corsetti (459690)

    Published 2018
    “…Since GBP5 and IL-10 are important molecules involved in host control of Brucella infection, we decided to investigate the role of mmu-miR-21a-5p in bacterial replication in macrophages. …”
  13. 5913
  14. 5914
  15. 5915

    Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

    Published 2024
    “…<div><p>Background</p><p>To estimate the effects on pain of two medications (low-dose naltrexone and gabapentin) compared to placebo among people with HIV (PWH) with heavy alcohol use and chronic pain.</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”
  16. 5916

    CONSORT flow diagram. by Judith I. Tsui (5983160)

    Published 2024
    “…<div><p>Background</p><p>To estimate the effects on pain of two medications (low-dose naltrexone and gabapentin) compared to placebo among people with HIV (PWH) with heavy alcohol use and chronic pain.</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”
  17. 5917

    Adverse events in placebo arm. by Judith I. Tsui (5983160)

    Published 2024
    “…<div><p>Background</p><p>To estimate the effects on pain of two medications (low-dose naltrexone and gabapentin) compared to placebo among people with HIV (PWH) with heavy alcohol use and chronic pain.</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”
  18. 5918

    Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

    Published 2024
    “…<div><p>Background</p><p>To estimate the effects on pain of two medications (low-dose naltrexone and gabapentin) compared to placebo among people with HIV (PWH) with heavy alcohol use and chronic pain.</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”
  19. 5919

    Table_5_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  20. 5920

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…</p><p>Methods</p><p>Cochrane Library, PubMed, Embase, Clinical Trials, and Web of Science were searched from inception to October 5, 2022. All randomized controlled trials (RCTs) were included. …”